October 2023 Stock Losers on News, Micro Caps Included
Ranked by the close-to-close change of the trading session each announcement landed in. How this is measured.
Data as of the trading session of , 21 of 22 completed market sessions produced ranked moves. That date is the last ranked session, not the last priced one, so follow-through dates run later.
On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.
Whole board, unfiltered
100
Ranked drops
-86.63%
Largest, SFT
99.0%
Below baseline, day +5
11.4%
Median deeper below baseline, day +5
Filter and sort
100 ranked drops in October 2023
Skip the ranked rows and go to the month summaryEvery percentage on a row, the follow-through readings included, is measured against that row's own pre-news close, which the row names. A day +5 reading is therefore the move from before the announcement, not a further change on top of the headline percentage.
| Rank | Symbol | close to close | Session | Catalyst | Announcement | from the pre-news close |
|---|---|---|---|---|---|---|
| 1 | SFT | -86.63% |
against the close of 2023-10-06
session reconstructed
Session detail |
Other Announcement |
Shift Technologies, Inc. to File Voluntary Chapter 11 Petition
17:00 ET after hours |
Five sessions later the drop was 8.9% bigger, at -94.31%. Month end -97.11% on 2023-10-31 |
| 2 | KTRA under $25M today | -79.68% |
against the close of 2023-10-30
session reconstructed
Session detail |
Clinical Trial Results |
Kintara Therapeutics Announces Preliminary Topline Results From GBM AGILE Study
08:00 ET premarket |
Five sessions later the drop was 11.1% bigger, at -88.56%. Month end -79.68% on 2023-10-31 same session This month ended before the fifth session after the move. |
| 3 | BETS | -78.99% |
against the close of 2023-10-25
session reconstructed
Session detail |
Offering / Dilution |
Bit Brother Limited Announces Pricing of $5.04 Million Registered Direct Offering
09:16 ET premarket |
Five sessions later the drop was 13.6% bigger, at -89.71%. Month end -88.65% on 2023-10-31 This month ended before the fifth session after the move. |
| 4 | ACAQ More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards | -70.72% |
against the close of 2023-10-18
session reconstructed
Session detail |
Reverse Merger / Shell |
e.GO and Athena Consumer Acquisition Corp. Complete Business Combination
12:55 ET intraday |
Month-end is not shown: no closing price is available for 2023-10-31. |
| 5 | AKRO | -62.61% |
against the close of 2023-10-09
session reconstructed
Session detail |
Clinical Trial Results |
Akero Therapeutics Reports Encouraging 36-Week Analysis of 96-Week Phase 2b SYMMETRY Study, with a Trend on Fibrosis Improvement and Statistically Significant Results for NASH Resolution, Markers of Liver Injury and Fibrosis, Insulin Sensitization and Lipoproteins
07:00 ET premarket |
Five sessions later the drop was 12.4% bigger, at -70.37%. Month end -75.44% on 2023-10-31 |
| 6 | SDC | -61.18% |
against the close of 2023-09-29
session reconstructed
Session detail |
Offering / Dilution |
SmileDirectClub Seeks to Execute Comprehensive Recapitalization to Strengthen the Business for Sustainable Growth
18:31 ET after hours |
Five sessions later the drop was 48.1% bigger, at -90.63%. Month end -88.96% on 2023-10-31 |
| 7 | RVLP | -60.61% |
against the close of 2023-10-11
session reconstructed
Session detail |
Other Announcement |
RVL Pharmaceuticals plc Announces Prepackaged Reorganization of Certain U.S. Subsidiaries
06:50 ET premarket |
Five sessions later the drop was 21.5% bigger, at -73.63%. Month end -88.37% on 2023-10-31 |
| 8 | ATHX | -60.00% |
against the close of 2023-10-09
session reconstructed
Session detail |
Clinical Trial Results |
Athersys Reports Interim Analysis Results of MASTERS-2 Clinical Study with MultiStem in Ischemic Stroke, Signs Memorandum of Understanding (MOU) for Global ARDS License with Healios
08:30 ET premarket |
Five sessions later the drop was 10.1% bigger, at -66.07%. Month end -88.37% on 2023-10-31 |
| 9 | TRML | -59.93% |
against the close of 2023-10-19
session reconstructed
Session detail |
M&A / Acquisition |
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
17:37 ET after hours |
19.0% of the drop was recovered five sessions later. Month end -39.38% on 2023-10-31 |
| 10 | SIEN | -56.16% |
against the close of 2023-10-30
session reconstructed
Session detail |
Earnings |
Sientra Reports Preliminary Unaudited Third Quarter 2023 Financial Results and Provides Update on Outlook
17:00 ET after hours |
12.8% of the drop was recovered five sessions later. Month end -56.16% on 2023-10-31 same session This month ended before the fifth session after the move. |
| 11 | GRTX under $25M today | -54.02% |
against the close of 2023-10-30
session reconstructed
Session detail |
Other Announcement |
Galera Announces Receipt of Type A Meeting Minutes and Strategic Update
07:00 ET premarket |
40.2% of the drop was recovered five sessions later. Month end -54.02% on 2023-10-31 same session This month ended before the fifth session after the move. |
| 12 | INBS under $25M today | -53.49% |
against the close of 2023-09-29
session reconstructed
Session detail |
Offering / Dilution |
Intelligent Bio Solutions Inc. Announces Pricing of $4,000,000 Underwritten Public Offering
08:32 ET premarket |
Five sessions later the drop was 22.7% bigger, at -65.61%. Month end -79.00% on 2023-10-31 |
| 13 | ETWO release reads positive | -50.11% |
against the close of 2023-10-10
session reconstructed
Session detail |
Earnings catalyst from a later release the same session Release reads positive, stock fell 50.11% |
E2open Announces Executive Transition
16:01 ET after hours |
40.5% of the drop was recovered five sessions later. Month end -34.17% on 2023-10-31 |
| 14 | OM | -49.93% |
against the close of 2023-10-12
session reconstructed
Session detail |
Earnings |
Outset Medical Reports Preliminary Third Quarter 2023 Financial Results
16:05 ET after hours |
8.3% of the drop was recovered five sessions later. Month end -47.71% on 2023-10-31 |
| 15 | SNOA under $25M today | -49.83% |
against the close of 2023-10-25
session reconstructed
Session detail |
Offering / Dilution |
Sonoma Pharmaceuticals, Inc. Announces Pricing of $1.7 Million Public Offering of Common Stock
09:10 ET premarket |
Five sessions later the drop was 7.8% bigger, at -53.74%. Month end -56.04% on 2023-10-31 This month ended before the fifth session after the move. |
| 16 | SILK | -49.04% |
against the close of 2023-10-10
session reconstructed
Session detail |
Earnings |
Silk Road Medical Announces Preliminary Third Quarter 2023 Revenue and Provides Revised 2023 Outlook
16:20 ET after hours |
2.8% of the drop was recovered five sessions later. Month end -46.32% on 2023-10-31 |
| 17 | VVPR release reads positive | -48.55% |
against the close of 2023-10-05
session reconstructed
Session detail |
Other Announcement Release reads positive, stock fell 48.55% |
TEMBO HONOURED WITH ELECTRICAL VEHICLE INNOVATION OF THE YEAR AWARD IN DUBAI, UNITED ARAB EMIRATES
09:00 ET premarket |
3.8% of the drop was recovered five sessions later. Month end -36.29% on 2023-10-31 |
| 18 | SYTA | -47.73% |
against the close of 2023-10-26
session reconstructed
Session detail |
Offering / Dilution |
Siyata Mobile Announces Pricing of $1.6 Million Public Offering of Common Shares
09:20 ET premarket |
Five sessions later the drop was 2.9% bigger, at -49.11%. Month end -49.42% on 2023-10-31 This month ended before the fifth session after the move. |
| 19 | PMVP More than one ranked move this month release reads positive 2+ ranked moves | -47.58% |
against the close of 2023-10-11
session reconstructed
Session detail |
Clinical Trial Results Release reads positive, stock fell 47.58% |
PMV Pharmaceuticals Updated PC14586 Phase 1 Data Demonstrated Anti-Tumor Activity Across Multiple Solid Tumor Types With a TP53 Y220C Mutation
12:30 ET intraday |
Five sessions later the drop was 32.3% bigger, at -62.95%. Month end -68.21% on 2023-10-31 |
| 20 | LICY | -45.81% |
against the close of 2023-10-20
session reconstructed
Session detail |
Other Announcement |
Li-Cycle Announces Review of the Rochester Hub Project
06:00 ET premarket |
Five sessions later the drop was 2.9% bigger, at -47.14%. Month end -40.97% on 2023-10-31 |
| 21 | MNY | -45.53% |
against the close of 2023-10-12
session reconstructed
Session detail |
Reverse Merger / Shell |
MoneyHero Group Successfully Completes Business Combination with Bridgetown Holdings Limited
19:00 ET after hours |
Five sessions later the drop was 34.3% bigger, at -61.14%. Month end -78.37% on 2023-10-31 |
| 22 | HYLN | -45.03% |
against the close of 2023-10-10
session reconstructed
Session detail |
Other Announcement |
Hyliion Holdings Announces Strategic Review of Alternatives for Electric Powertrain Business
16:15 ET after hours |
7.4% of the drop was recovered five sessions later. Month end -49.89% on 2023-10-31 |
| 23 | SGH | -44.44% |
against the close of 2023-10-12
session reconstructed
Session detail |
Earnings |
SGH Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results
16:05 ET after hours |
3.7% of the drop was recovered five sessions later. Month end -41.90% on 2023-10-31 |
| 24 | SSU | -43.73% |
against the close of 2023-09-29
session reconstructed
Session detail |
Other Announcement |
SIGNA Sports United N.V. Accelerates Strategic Realignment and Restructuring Program
07:30 ET premarket |
Five sessions later the drop was 37.2% bigger, at -60.01%. Month end -97.42% on 2023-10-31 |
| 25 | APLM More than one ranked move this month 2+ ranked moves | -43.24% |
against the close of 2023-10-20
session reconstructed
Session detail |
Other Announcement |
Apollomics Announces Efficacy of Vebreltinib in NSCLC Patients with MetEx14 Skipping Mutation Achieving an Overall Response Rate (ORR) of 75%
08:30 ET premarket |
Five sessions later the drop was 12.3% bigger, at -48.57%. Month end -54.29% on 2023-10-31 |
| 26 | WISA under $25M today | -40.20% |
against the close of 2023-10-13
session reconstructed
Session detail |
Offering / Dilution |
WiSA Technologies Announces Pricing of $4.8 Million Public Offering of Series B Convertible Redeemable Preferred Stock and Warrants
13:30 ET intraday |
Five sessions later the drop was 38.4% bigger, at -55.63%. Month end -62.99% on 2023-10-31 |
| 27 | MWG under $25M today | -39.60% |
against the close of 2023-10-30
session reconstructed
Session detail |
Earnings |
Multi Ways Holdings Announces First Half 2023 Unaudited Financial Results, Provides Corporate Updates
07:00 ET premarket |
Five sessions later the drop was 9.2% bigger, at -43.25%. Month end -39.60% on 2023-10-31 same session This month ended before the fifth session after the move. |
| 28 | COMM | -38.84% |
against the close of 2023-10-27
session reconstructed
Session detail |
Earnings |
CommScope Announces Preliminary Third Quarter 2023 Results
08:05 ET premarket |
12.8% of the drop was recovered five sessions later. Month end -38.84% on 2023-10-31 This month ended before the fifth session after the move. |
| 29 | AGFY | -38.84% |
against the close of 2023-10-20
session reconstructed
Session detail |
Other Announcement |
Agrify Receives Nasdaq Staff Determination of Non-Compliance with Listing Rule 5250(c)(1)
17:04 ET after hours |
Five sessions later the drop was 11.7% bigger, at -43.39%. Month end -46.69% on 2023-10-31 |
| 30 | BWMX release reads positive | -38.20% |
against the close of 2023-10-26
session reconstructed
Session detail |
Earnings Release reads positive, stock fell 38.20% |
Betterware Reports Third Quarter 2023 Results
16:05 ET after hours |
40.7% of the drop was recovered five sessions later. Month end -27.53% on 2023-10-31 This month ended before the fifth session after the move. |
| 31 | SRPT | -37.47% |
against the close of 2023-10-30
session reconstructed
Session detail |
Clinical Trial Results |
Sarepta Therapeutics Announces Topline Results from EMBARK, a Global Pivotal Study of ELEVIDYS Gene Therapy for Duchenne Muscular Dystrophy
16:01 ET after hours |
38.7% of the drop was recovered five sessions later. Month end -37.47% on 2023-10-31 same session This month ended before the fifth session after the move. |
| 32 | CMBM under $25M today | -36.24% |
against the close of 2023-10-04
session reconstructed
Session detail |
Earnings |
Cambium Networks Corporation Announces Preliminary Third Quarter 2023 Revenues and Reporting Date
16:30 ET after hours |
5.2% of the drop was recovered five sessions later. Month end -37.12% on 2023-10-31 |
| 33 | FEMY release reads positive | -35.99% |
against the close of 2023-10-02
session reconstructed
Session detail |
Other Announcement Release reads positive, stock fell 35.99% |
Femasys Inc. MDSAP Surveillance Audit Successfully Completed
08:30 ET premarket |
Five sessions later the drop was 52.2% bigger, at -54.76%. Month end -61.95% on 2023-10-31 |
| 34 | NXU under $25M today More than one ranked move this month 2+ ranked moves | -35.65% |
against the close of 2023-10-18
session reconstructed
Session detail |
Offering / Dilution |
Nxu, Inc. Announces $3.0 Million Public Offering of Common Stock
09:15 ET premarket |
Five sessions later the drop was 30.5% bigger, at -46.52%. Month end -50.14% on 2023-10-31 |
| 35 | CAMP | -35.29% |
against the close of 2023-10-05
session reconstructed
Session detail |
Earnings |
CalAmp Reports Second Quarter Fiscal Year 2024 Financial Results
16:30 ET after hours |
Five sessions later the drop was 36.7% bigger, at -48.23%. Month end -46.68% on 2023-10-31 |
| 36 | RVMD Also on the opposite board this month on both boards | -34.38% |
against the close of 2023-10-20
session reconstructed
Session detail |
Clinical Trial Results |
Revolution Medicines Presents Promising Clinical Activity and Safety Data from Phase 1/1b Trial of RMC-6236
02:30 ET premarket |
0.0% of the drop was recovered five sessions later. Month end -29.21% on 2023-10-31 |
| 37 | HOFV under $25M today | -33.56% |
against the close of 2023-10-10
session reconstructed
Session detail |
Offering / Dilution |
Hall of Fame Resort & Entertainment Company Announces Proposed Public Offering of Common Stock and Warrants
16:10 ET after hours |
Five sessions later the drop was 40.4% bigger, at -47.11%. Month end -41.78% on 2023-10-31 |
| 38 | B release reads positive | -32.82% |
against the close of 2023-10-26
session reconstructed
Session detail |
Earnings catalyst from a later release the same session Release reads positive, stock fell 32.82% |
Integrum moves into Turkey
08:02 ET premarket |
23.8% of the drop was recovered five sessions later. Month end -30.65% on 2023-10-31 This month ended before the fifth session after the move. |
| 39 | MKFG | -32.40% |
against the close of 2023-10-23
session reconstructed
Session detail |
Earnings |
Markforged Schedules Third Quarter 2023 Earnings Announcement; Provides Preliminary Third Quarter Results and Updates 2023 Revenue Guidance
16:30 ET after hours |
Five sessions later the drop was 24.0% bigger, at -40.17%. Month end -40.17% on 2023-10-31 |
| 40 | PHIO under $25M today Also on the opposite board this month release reads positive on both boards | -32.31% |
against the close of 2023-10-11
session reconstructed
Session detail |
Other Announcement Release reads positive, stock fell 32.31% |
Phio Pharmaceuticals Announces Upcoming Presentation at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
11:00 ET intraday |
Five sessions later the drop was 46.4% bigger, at -47.31%. Month end -52.31% on 2023-10-31 |
| 41 | FFIE | -32.18% |
against the close of 2023-10-18
session reconstructed
Session detail |
Other Announcement |
Faraday Future Completes the Sale-Leaseback of its Hanford, California Manufacturing Facility
07:00 ET premarket |
Five sessions later the drop was 19.7% bigger, at -38.51%. Month end -39.08% on 2023-10-31 |
| 42 | OMER | -32.16% |
against the close of 2023-10-13
session reconstructed
Session detail |
Clinical Trial Results |
Omeros Corporation Provides Update on Interim Analysis of ARTEMIS-IGAN Phase 3 Trial of Narsoplimab in IgA Nephropathy
07:30 ET premarket |
Five sessions later the drop was 57.5% bigger, at -50.66%. Month end -47.58% on 2023-10-31 |
| 43 | LIPO under $25M today Also on the opposite board this month on both boards | -31.95% |
against the close of 2023-10-25
session reconstructed
Session detail |
Offering / Dilution |
Lipella Pharmaceuticals Announces Closing of $2 Million Private Placement Priced At-The-Market Under Nasdaq Rules
16:05 ET after hours |
0.0% of the drop was recovered five sessions later. Month end -33.14% on 2023-10-31 This month ended before the fifth session after the move. |
| 44 | COCH More than one ranked move this month 2+ ranked moves | -31.58% |
against the close of 2023-09-29
session reconstructed
Session detail |
Uplisting / Compliance |
Breakthrough Hearing Health Technology Firm, Envoy Medical Begins Trading On NASDAQ
07:00 ET premarket |
Five sessions later the drop was 35.2% bigger, at -42.69%. Month end -82.61% on 2023-10-31 |
| 45 | TRKA | -31.19% |
against the close of 2023-10-20
session reconstructed
Session detail |
Other Announcement |
Troika Media Group Inc. Reports Revenue of $58.7 million and $117.7 million, for the Three and Six Months Ended June 30, 2023
17:30 ET after hours |
Five sessions later the drop was 16.1% bigger, at -36.22%. Month end -5.45% on 2023-10-31 |
| 46 | AJX release reads positive | -30.77% |
against the close of 2023-10-20
session reconstructed
Session detail |
M&A / Acquisition (terminated) Release reads positive, stock fell 30.77% |
Ellington Financial and Great Ajax Corp. Announce Mutual Termination of Merger Agreement
16:13 ET after hours |
Five sessions later the drop was 11.7% bigger, at -34.38%. Month end -32.18% on 2023-10-31 |
| 47 | WGS | -30.34% |
against the close of 2023-10-30
session reconstructed
Session detail |
Earnings |
GeneDx Reports Third Quarter 2023 Financial Results and Business Highlights
16:05 ET after hours |
Five sessions later the drop was 35.8% bigger, at -41.20%. Month end -30.34% on 2023-10-31 same session This month ended before the fifth session after the move. |
| 48 | HRMY | -30.25% |
against the close of 2023-10-12
session reconstructed
Session detail |
Clinical Trial Results |
HARMONY BIOSCIENCES ANNOUNCES TOPLINE DATA FROM PHASE 3 INTUNE STUDY EVALUATING PITOLISANT IN PATIENTS WITH IDIOPATHIC HYPERSOMNIA
08:00 ET premarket |
Five sessions later the drop was 10.7% bigger, at -33.49%. Month end -22.22% on 2023-10-31 |
| 49 | SILC | -30.23% |
against the close of 2023-10-25
session reconstructed
Session detail |
Earnings |
Silicom Reports Q3'23 Results: $30.1M Revenues with $0.30 Non-GAAP EPS
08:15 ET premarket |
Five sessions later the drop was 1.6% bigger, at -30.72%. Month end -31.71% on 2023-10-31 This month ended before the fifth session after the move. |
| 50 | SDA release reads positive | -29.00% |
against the close of 2023-10-25
session reconstructed
Session detail |
Offering / Dilution Release reads positive, stock fell 29.00% |
SunCar Technology Group Inc. Announces $21 Million Follow-on Offering
09:25 ET premarket |
Five sessions later the drop was 65.1% bigger, at -47.87%. Month end -44.42% on 2023-10-31 This month ended before the fifth session after the move. |
| 51 | BAER Also on the opposite board this month on both boards | -28.96% |
against the close of 2023-10-17
session reconstructed
Session detail |
Offering / Dilution |
Bridger Aerospace Announces $70 Million Proposed Public Follow-On Offering to Fund Growth Initiatives
16:20 ET after hours |
33.0% of the drop was recovered five sessions later. Month end -17.46% on 2023-10-31 |
| 52 | VS under $25M today | -28.86% |
against the close of 2023-10-12
session reconstructed
Session detail |
Offering / Dilution |
Versus Systems Inc. Announces Pricing of $3.0 Million Public Offering
11:55 ET intraday |
Five sessions later the drop was 42.9% bigger, at -41.24%. Month end -49.24% on 2023-10-31 |
| 53 | TYGO | -28.86% |
against the close of 2023-10-06
session reconstructed
Session detail |
Earnings |
Tigo Energy Announces Preliminary Financial Results and Reporting Date of November 7, 2023 for Fiscal Third Quarter 2023
08:30 ET premarket |
Five sessions later the drop was 81.4% bigger, at -52.35%. Month end -64.70% on 2023-10-31 |
| 54 | HRYU under $25M today | -28.78% |
against the close of 2023-10-25
session reconstructed
Session detail |
Other Announcement |
Hanryu Holdings is Honored to Ring the Nasdaq Opening Bell Today, October 26, 2023, at 9:30 AM ET
07:30 ET premarket |
Five sessions later the drop was 7.1% bigger, at -30.81%. Month end -31.73% on 2023-10-31 This month ended before the fifth session after the move. |
| 55 | SONN under $25M today | -28.73% |
against the close of 2023-10-24
session reconstructed
Session detail |
Offering / Dilution |
Sonnet BioTherapeutics Announces Pricing of $4.55 Million Underwritten Public Offering
07:30 ET premarket |
Five sessions later the drop was 15.4% bigger, at -33.15%. Month end -31.49% on 2023-10-31 This month ended before the fifth session after the move. |
| 56 | VBLT release reads positive | -28.63% |
against the close of 2023-10-11
session reconstructed
Session detail |
Earnings Release reads positive, stock fell 28.63% |
VBL Therapeutics Announces Results of Annual and Special Shareholder Meeting
09:00 ET premarket |
Month-end is not shown: no closing price is available for 2023-10-31. |
| 57 | THTX | -28.05% |
against the close of 2023-10-25
session reconstructed
Session detail |
Offering / Dilution |
Theratechnologies Announces Pricing of US$25 Million Public Offering of Common Shares and Concurrent Private Placement
08:00 ET premarket |
41.5% of the drop was recovered five sessions later. Month end -29.69% on 2023-10-31 This month ended before the fifth session after the move. |
| 58 | EFXT release reads positive | -27.57% |
against the close of 2023-09-29
session reconstructed
Session detail |
Other Announcement Release reads positive, stock fell 27.57% |
Enerflex Ltd. Announces Chief Financial Officer Transition
17:00 ET after hours |
19.6% of the drop was recovered five sessions later. Month end -30.54% on 2023-10-31 |
| 59 | PLAG under $25M today release reads positive | -27.39% |
against the close of 2023-10-09
session reconstructed
Session detail |
Contract / Partnership Release reads positive, stock fell 27.39% |
Planet Green Holdings Corp Subsidiary Allinyson Ltd Forges Strategic Partnership with MetaMind AI Limited on AI Technology Solutions
08:30 ET premarket |
Five sessions later the drop was 10.7% bigger, at -30.32%. Month end -32.23% on 2023-10-31 |
| 60 | COCH More than one ranked move this month 2+ ranked moves | -27.36% |
against the close of 2023-10-09
session reconstructed
Session detail |
Contract / Partnership |
Envoy Medical Announces Settlement Contract
08:30 ET premarket |
Five sessions later the drop was 80.0% bigger, at -49.25%. Month end -69.65% on 2023-10-31 |
| 61 | SEDG | -27.27% |
against the close of 2023-10-19
session reconstructed
Session detail |
Earnings |
SolarEdge Announces Preliminary Financial Results; Will Announce Financial Results for the Third Quarter 2023 on Wednesday, November 1, 2023
16:10 ET after hours |
Five sessions later the drop was 19.0% bigger, at -32.45%. Month end -33.37% on 2023-10-31 |
| 62 | LQR under $25M today | -27.23% |
against the close of 2023-10-12
session reconstructed
Session detail |
Offering / Dilution |
LQR House Inc. Announces Pricing of $5.4 Million Public Offering
09:05 ET premarket |
Five sessions later the drop was 77.2% bigger, at -48.26%. Month end -58.96% on 2023-10-31 |
| 63 | ATEN | -27.22% |
against the close of 2023-10-03
session reconstructed
Session detail |
Earnings |
A10 Networks Reports Preliminary Third Quarter Financial Results
17:00 ET after hours |
1.2% of the drop was recovered five sessions later. Month end -28.35% on 2023-10-31 |
| 64 | VICR | -26.58% |
against the close of 2023-10-24
session reconstructed
Session detail |
Earnings |
Vicor Corporation Reports Results for the Third Quarter Ended September 30, 2023
16:05 ET after hours |
Five sessions later the drop was 14.8% bigger, at -30.51%. Month end -27.17% on 2023-10-31 This month ended before the fifth session after the move. |
| 65 | IKT | -26.43% |
against the close of 2023-10-03
session reconstructed
Session detail |
FDA & Regulatory |
Inhibikase Therapeutics Receives FDA Orphan Drug Designation for Risvodetinib for the Treatment of Multiple System Atrophy
08:30 ET premarket |
Five sessions later the drop was 45.9% bigger, at -38.57%. Month end -36.74% on 2023-10-31 |
| 66 | APLM More than one ranked move this month 2+ ranked moves | -26.23% |
against the close of 2023-10-25
session reconstructed
Session detail |
Other Announcement |
Apollomics Announces Report of Activity of Vebreltinib in Glioblastoma Multiforme (GBM) with PTPRZ-MET Fusion
08:50 ET premarket |
75.9% of the drop was recovered five sessions later. Month end +3.90% on 2023-10-31 This month ended before the fifth session after the move. |
| 67 | CNXA release reads positive | -26.19% |
against the close of 2023-10-05
session reconstructed
Session detail |
Other Announcement Release reads positive, stock fell 26.19% |
Connexa Announces Overwhelming Demand for Pickleball Launcher
07:45 ET premarket |
Five sessions later the drop was 49.4% bigger, at -39.12%. Month end -70.95% on 2023-10-31 |
| 68 | PMVP More than one ranked move this month 2+ ranked moves | -26.01% |
against the close of 2023-10-10
session reconstructed
Session detail |
Clinical Trial Results |
PMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics and Host a KOL Webinar
12:00 ET intraday |
Five sessions later the drop was 157.8% bigger, at -67.06%. Month end -76.48% on 2023-10-31 |
| 69 | VTYX | -25.93% |
against the close of 2023-10-09
session reconstructed
Session detail |
Clinical Trial Results |
Ventyx Biosciences Announces Positive Results from the Phase 2 Trial of VTX002 in Patients with Moderate-to-Severely Active Ulcerative Colitis
16:01 ET after hours |
Five sessions later the drop was 60.8% bigger, at -41.70%. Month end -51.93% on 2023-10-31 |
| 70 | ACAQ More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards | -25.87% |
against the close of 2023-09-29
session reconstructed
Session detail |
Reverse Merger / Shell |
Next.e.GO Mobile SE and Athena Consumer Acquisition Corp. Announce Athena’s Stockholders’ Approval of the Proposed Business Combination
13:11 ET intraday |
22.8% of the drop was recovered five sessions later. Month-end is not shown: no closing price is available for 2023-10-31. |
| 71 | ATLX | -25.53% |
against the close of 2023-10-20
session reconstructed
Session detail |
Earnings |
Atlas Lithium Provides Third Quarter 2023 Corporate Update
11:37 ET intraday |
32.2% of the drop was recovered five sessions later. Month end -17.17% on 2023-10-31 |
| 72 | BDC | -25.45% |
against the close of 2023-10-12
session reconstructed
Session detail |
Earnings |
Belden Announces Preliminary Third Quarter Results
16:15 ET after hours |
2.8% of the drop was recovered five sessions later. Month end -25.58% on 2023-10-31 |
| 73 | NXU under $25M today More than one ranked move this month release reads positive 2+ ranked moves | -25.25% |
against the close of 2023-10-09
session reconstructed
Session detail |
Earnings Release reads positive, stock fell 25.25% |
Nxu Achieves Important Milestones in Pivotal Q3 2023
06:30 ET premarket |
Five sessions later the drop was 111.3% bigger, at -53.36%. Month end -77.08% on 2023-10-31 |
| 74 | LMDX Also on the opposite board this month on both boards | -25.00% |
against the close of 2023-10-27
session reconstructed
Session detail |
Uplisting / Compliance |
LumiraDx Announces Receipt of NASDAQ Delisting Determination; Plans to Appeal
16:45 ET after hours |
13.3% of the drop was recovered five sessions later. Month end -17.42% on 2023-10-31 This month ended before the fifth session after the move. |
| 75 | PETS | -24.95% |
against the close of 2023-10-30
session reconstructed
Session detail |
Earnings |
PetMeds® Announces Its Second Quarter Financial Results
16:01 ET after hours |
11.4% of the drop was recovered five sessions later. Month end -24.95% on 2023-10-31 same session This month ended before the fifth session after the move. |
| 76 | NVNI under $25M today | -24.88% |
against the close of 2023-10-02
session reconstructed
Session detail |
Uplisting / Compliance |
Nuvini Provides Highlights Outlook and Growth Opportunities as it Begins Trading
08:00 ET premarket |
Five sessions later the drop was 99.4% bigger, at -49.60%. Month end -60.31% on 2023-10-31 |
| 77 | ALGN | -24.88% |
against the close of 2023-10-25
session reconstructed
Session detail |
Earnings |
Align Technology Announces Third Quarter 2023 Financial Results
16:20 ET after hours |
2.8% of the drop was recovered five sessions later. Month end -27.24% on 2023-10-31 This month ended before the fifth session after the move. |
| 78 | GTLS | -24.87% |
against the close of 2023-10-26
session reconstructed
Session detail |
Earnings catalyst from a later release the same session |
Chart Industries Divests American Fan to Fairbanks Morse Defense
06:25 ET premarket |
33.9% of the drop was recovered five sessions later. Month end -20.71% on 2023-10-31 This month ended before the fifth session after the move. |
| 79 | ABOS | -24.84% |
against the close of 2023-10-26
session reconstructed
Session detail |
Clinical Trial Results |
Acumen Pharmaceuticals Presents Late-Breaker Phase 1 Updates Exploring Novel Target Engagement, Dosing Regimen and Safety Findings for ACU193 in Early Alzheimer’s Disease at the 16th Annual Clinical Trials on Alzheimer’s Disease
09:25 ET premarket |
Five sessions later the drop was 28.8% bigger, at -31.99%. Month end -41.93% on 2023-10-31 This month ended before the fifth session after the move. |
| 80 | INM under $25M today Also on the opposite board this month on both boards | -24.18% |
against the close of 2023-10-24
session reconstructed
Session detail |
Offering / Dilution |
InMed Pharmaceuticals Announces $5.2 Million Private Placement and Preferred Investment Option Exercise Priced At-the-Market under Nasdaq Rules
16:38 ET after hours |
Five sessions later the drop was 121.3% bigger, at -53.50%. Month end -51.09% on 2023-10-31 This month ended before the fifth session after the move. |
| 81 | VNRX under $25M today | -24.17% |
against the close of 2023-10-18
session reconstructed
Session detail |
Other Announcement |
Measuring Nucleosomes Using Nu.Q® NETs is a Promising Biomarker for Septic Shock
08:00 ET premarket |
30.4% of the drop was recovered five sessions later. Month end -12.53% on 2023-10-31 |
| 82 | ADIL under $25M today | -24.11% |
against the close of 2023-10-19
session reconstructed
Session detail |
Offering / Dilution |
Adial Pharmaceuticals Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
08:00 ET premarket |
Five sessions later the drop was 16.2% bigger, at -28.01%. Month end -31.56% on 2023-10-31 |
| 83 | PAC | -24.05% |
against the close of 2023-10-04
session reconstructed
Session detail |
Other Announcement |
Grupo Aeroportuario del Pacifico Announces Government Action to Change Tariff Base Regulation
20:39 ET after hours |
30.4% of the drop was recovered five sessions later. Month end -28.85% on 2023-10-31 |
| 84 | VSTO | -23.72% |
against the close of 2023-10-13
session reconstructed
Session detail |
M&A / Acquisition |
Vista Outdoor Enters into Definitive Agreement to Sell Sporting Products Business to Czechoslovak Group for $1.91 Billion
08:00 ET premarket |
Five sessions later the drop was 14.4% bigger, at -27.13%. Month end -23.41% on 2023-10-31 |
| 85 | TRU | -23.30% |
against the close of 2023-10-23
session reconstructed
Session detail |
Earnings |
TransUnion Announces Third Quarter 2023 Results
06:35 ET premarket |
Five sessions later the drop was 38.8% bigger, at -32.34%. Month end -32.34% on 2023-10-31 |
| 86 | HARP Also on the opposite board this month on both boards | -23.26% |
against the close of 2023-10-20
session reconstructed
Session detail |
Clinical Trial Results |
Harpoon Therapeutics Announces Updated Interim Tolerability and Response Data from Phase 1/2 Clinical Trial of T Cell Engager HPN328 at ESMO Congress 2023
11:31 ET intraday |
Five sessions later the drop was 20.6% bigger, at -28.05%. Month end -26.74% on 2023-10-31 |
| 87 | ISPO | -23.08% |
against the close of 2023-10-04
session reconstructed
Session detail |
Contract / Partnership |
Inspirato Completes $25 Million Investment from Capital One Ventures, Solidifying New Strategic Partnership
16:30 ET after hours |
Five sessions later the drop was 73.6% bigger, at -40.06%. Month end -64.90% on 2023-10-31 |
| 88 | RIVN | -22.88% |
against the close of 2023-10-04
session reconstructed
Session detail |
Offering / Dilution |
Rivian Automotive, Inc. Announces Proposed Green Convertible Senior Notes Offering
17:42 ET after hours |
19.6% of the drop was recovered five sessions later. Month end -31.53% on 2023-10-31 |
| 89 | PTCT | -22.71% |
against the close of 2023-10-26
session reconstructed
Session detail |
Earnings |
PTC Therapeutics Provides Corporate Update and Reports Third Quarter Financial Results
16:05 ET after hours |
18.7% of the drop was recovered five sessions later. Month end -21.71% on 2023-10-31 This month ended before the fifth session after the move. |
| 90 | GBIO | -22.51% |
against the close of 2023-10-17
session reconstructed
Session detail |
Other Announcement |
Generation Bio Announces Breakthrough in its Non-Viral Genetic Medicine Platform with Novel “Immune-Quiet” DNA
06:59 ET premarket |
Five sessions later the drop was 210.3% bigger, at -69.84%. Month end -69.83% on 2023-10-31 |
| 91 | LAB | -22.22% |
against the close of 2023-10-03
session reconstructed
Session detail |
M&A / Acquisition |
Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools
08:00 ET premarket |
Five sessions later the drop was 68.4% bigger, at -37.41%. Month end -26.30% on 2023-10-31 |
| 92 | OST under $25M today | -22.02% |
against the close of 2023-10-06
session reconstructed
Session detail |
Other Announcement |
Ostin Technology Group Co. Secured New Purchase Orders of Treadmill Screen Products; Officially Opens Douyin Store with Latest Smartwatch Products Now Available for Purchase
08:00 ET premarket |
Five sessions later the drop was 19.0% bigger, at -26.21%. Month end -24.27% on 2023-10-31 |
| 93 | MXL | -21.96% |
against the close of 2023-10-25
session reconstructed
Session detail |
Earnings |
MaxLinear, Inc. Announces Third Quarter 2023 Financial Results
16:05 ET after hours |
32.4% of the drop was recovered five sessions later. Month end -17.39% on 2023-10-31 This month ended before the fifth session after the move. |
| 94 | ACMR | -21.92% |
against the close of 2023-10-26
session reconstructed
Session detail |
Earnings |
ACM Research Announces Preliminary Unaudited Revenue Range for Third Quarter 2023
07:00 ET premarket |
35.9% of the drop was recovered five sessions later. Month end -22.55% on 2023-10-31 This month ended before the fifth session after the move. |
| 95 | AGRI under $25M today | -21.79% |
against the close of 2023-10-10
session reconstructed
Session detail |
Other Announcement |
AgriFORCE-RCS Hydroxyl Technology Selected as One of the Top Innovations at EXPO Guanajuato 2023
09:00 ET premarket |
Five sessions later the drop was 48.3% bigger, at -32.31%. Month end -50.26% on 2023-10-31 |
| 96 | ON | -21.77% |
against the close of 2023-10-27
session reconstructed
Session detail |
Earnings |
onsemi Third Quarter 2023 Results Exceed Expectations
08:00 ET premarket |
4.9% of the drop was recovered five sessions later. Month end -25.00% on 2023-10-31 This month ended before the fifth session after the move. |
| 97 | OCEA under $25M today | -21.71% |
against the close of 2023-10-02
session reconstructed
Session detail |
Contract / Partnership catalyst from a later release the same session |
Ocean Biomedical Announces Newly Published Findings Demonstrating Ability to Restore Treatment Sensitivity to AstraZeneca’s Leading Lung Cancer Drug After Resistance Has Formed, and Enhanced Tumor Suppression in EGFR-Mutation Lung Cancers
08:01 ET premarket |
Five sessions later the drop was 52.6% bigger, at -33.14%. Month end -52.00% on 2023-10-31 |
| 98 | TBI | -21.67% |
against the close of 2023-10-23
session reconstructed
Session detail |
Earnings catalyst from a later release the same session |
TrueBlue Announces Greg Netolicky as Chief People Officer
16:05 ET after hours |
12.5% of the drop was recovered five sessions later. Month end -18.96% on 2023-10-31 |
| 99 | ALGS | -21.52% |
against the close of 2023-10-20
session reconstructed
Session detail |
Offering / Dilution |
Aligos Therapeutics Announces $92 Million Private Placement Financing
08:00 ET premarket |
26.6% of the drop was recovered five sessions later. Month end -21.05% on 2023-10-31 |
| 100 | MDNA | -21.24% |
against the close of 2023-10-26
session reconstructed
Session detail |
Uplisting / Compliance |
Medicenna Announces Nasdaq Delisting and Cutback of Management Team
07:55 ET premarket |
It recovered the whole drop and closed 4.59% above the pre-news price. Month end -27.82% on 2023-10-31 This month ended before the fifth session after the move. |
NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today. 309 events never entered this month's eligible pool, because the ticker is a warrant, a unit, a right or a preferred rather than common stock, or carries a stored capitalization above $10 trillion, which is larger than any company has reached. Exclude the $5M to $25M band
2 events were left out of this board because the vendor names the ticker as a preferred, a note, a depositary share or a fund rather than a company's common stock.
2 events were left out of this board because the price series changes basis between the baseline close and the measured one, so the two prices do not describe the same shares of the same company and their ratio measures a corporate action, or a change in what the ticker identifies, rather than a move.
6 events were left out of this board because the measured session set no price of its own, trading either nothing at all or barely moving on an ordinary day's volume, so the figure it would be ranked on is a price carried onto the tape rather than a close.
1 event was left out of this board because the measured session changed hands for less than $25,000 in total, so the percentage prices a handful of shares rather than a move anyone could have taken.
1 event was left out of this board because the ticker had not traded for more than 10 days before the measured session, so no comparable prior close exists.
Company names are not shown on months older than a year, because only the current holder of each ticker is known.
Whole board, unfiltered
In October 2023, the median decliner was 11.4% deeper below its pre-news close five sessions later; the largest catalyst group was Earnings, 31 of the 100 events, at a median of -28.6%.
Close-to-close change on the measured trading session, against the previous close.
NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.
Which catalysts drove the board
Swipe the table sideways for the day +5 columns.
| Catalyst | Events | Share of board | Median move close to close | Median at day +5 | Still below the pre-news close at day +5 |
|---|---|---|---|---|---|
| Earnings | 31 | 31.0% | -28.6% | -30.6% of 30 | 100.0% of 30 |
| Other Announcement | 22 | 22.0% | -32.2% | -40.4% | 100.0% of 22 |
| Offering / Dilution | 19 | 19.0% | -29.0% | -47.1% | 100.0% of 19 |
| Clinical Trial Results | 12 | 12.0% | -33.3% | -46.2% | 100.0% of 12 |
| M&A / Acquisition | 4 | 4.0% | Fewer than 10 events in this group, so no figures are shown. | ||
The day +5 figures are measured over the events in each group that have a five-session close, the count printed beside them, not over every event in the group.
4 other catalyst types, 12 events: Contract / Partnership, Uplisting / Compliance, Reverse Merger / Shell, FDA & Regulatory.
How much of the drop held
| Horizon | Still below the pre-news close close to close | Median change since the measured close as a share of the drop |
|---|---|---|
| Day +1 | 99.0% of 99 | 1.8% deeper below baseline, of 99 |
| Day +5 | 99.0% of 98 | 11.4% deeper below baseline, of 98 |
| Month end | 98.9% of 90 | 16.3% deeper below baseline, of 90 |
| Month end falls before day +5 for 24 of these 90 events, so this row is not a later horizon than the one above it. 90 of the 100 events have a month-end close later than the measured session; 7 have it on the measured session itself, and 3 have no month-end close. | ||
Both figures in a row are measured over the events that have a close at that horizon, the count printed beside each of them, not over all 100 events on this board, which is why the denominators differ between rows.
Repeat runners
Some companies move on news more than once. The left list holds the ones that moved twice or more this month; the right list holds the ones that also moved in the months before it. The ranking above shows one row per move, so a name that keeps coming back is only visible here.
Moved twice or more inside October 2023
Two or more ranked moves this month, each on a different trading day.
| Symbol | Measured sessions | Largest drop |
|---|---|---|
| ACAQ | 2Reverse Merger / Shell | -70.72% |
| PMVP | 2Clinical Trial Results | -47.58% |
| APLM | 2Other Announcement | -43.24% |
| NXU | 2Offering / Dilution, Earnings | -35.65% |
| COCH | 2Uplisting / Compliance, Contract / Partnership | -31.58% |
Also fallen on news in earlier months
Ranked in at least two of the three months before this one. They are listed whether or not they rank this month, which is why the months are named.
| Symbol | Months | Largest drop |
|---|---|---|
| PALI | 2023-09, 2023-08 | -62.70% |
| AGRIthis month too | 2023-09, 2023-07 | -26.55% |
| BCDA | 2023-09, 2023-07 | -44.70% |
| EFSH | 2023-09, 2023-07 | -31.26% |
| TNXP | 2023-09, 2023-07 | -39.89% |
| AULT | 2023-09, 2023-07 | -29.49% |
| CGRN | 2023-09, 2023-08 | -31.02% |
What the board was made of
Price before the move
Price bands are not shown on months older than a year, because the stored prices are adjusted for splits done since and a company that has reverse-split lands in a band its shares never traded in.
When the announcement landed
Volume against normal
Industry
29 other industries, 32 events
Industry not known: 29.0%
When the release and the price disagreed
14 events on this board carry the flag.
Flagged events sat 1.7 percentage points below the rest of the board five sessions later.
- Median at day +5, flagged
- -39.1%
- Median at day +5, not flagged
- -37.4%
Against September 2023
100 events in the comparable window.
September 2023 median -22.0%, selected from the 7,916 events in that month's eligible pool
October 2023 median -29.0%, 7.0 points steeper than September 2023. October 2023's median is taken over the 100 ranked rows, selected from the 10,487 events in that month's eligible pool.
The two windows drew on pools of very different size, so part of the gap between the medians is how deep into each pool the top hundred reaches rather than how severe the moves were.
How this ranking is measured
Close-to-close change on the measured trading session, against the previous close.
- An announcement before 16:00 ET is measured on that trading day; one at or after 16:00 ET, or on a weekend, is measured on the next trading day.
- One row per company and measured session. Other announcements the company made in the same session are listed inside the row.
- A ranking is a coincidence of news and price on the same session, not proof that the news caused the move. Part of an intraday move can precede the announcement.
- No Stated Cause marks a release in which the company itself says it knows of no reason for the move, while Other Announcement marks a release these rules could not classify.
Eligibility uses each company's capitalization today, not its capitalization at the time. Archive boards can therefore change as companies grow or shrink.
Prices are adjusted for stock splits the company has done since, so an older row's dollar figures are stated on today's share count and are not the prices that traded that day. The percentage move, the dollar volume and the relative volume are unaffected, because both prices carry the same adjustment. The session's share count carries the adjustment too, so the shares figure beside the dollar volume is that count restated on today's basis rather than the number of shares that changed hands. Where the ticker was retired the price series stops with it and no later adjustment reached it, so those rows are marked as traded and their dollars are the ones that changed hands on the day.
Market cap is not shown on months older than a year, because only today's figure exists.
NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.
On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.
This archive starts at 2020-04, the first month with ranked moves.